HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos · Apr 19, 2025 · 1h 39m

Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics:

Introduction (0:00)

HER2-Positive Breast Cancer — Dr O'Shaughnessy (3:13)

Triple-Negative Breast Cancer — Dr Bardia (32:56)

Personalizing Adjuvant Therapy for Patients with HR-Positive Breast Cancer — Dr Borges (57:35)

Current Role of CDK4/6 Inhibitors in the Localized Setting — Dr Burstein (1:25:15)

CME information and select publications